It seems that there is no content provided for summarization. Please provide the text you'd like summarized, and I'll be happy to help!
GSK has been in the news recently: Investors who experienced financial losses in GSK plc between February 5, 2020, and August 14, 2022, are eligible to participate in a class action lawsuit due by April 7, 2025, due to alleged misleading statements about Zantac. Several law firms, including Schall Law Firm and Rosen Law Firm, are advising affected shareholders to register for this class action.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
